Aim: Although several studies reported the measurement of fetal oxygen saturation using fetal pulse oximetry (FPO) for evaluation of the fetal intrapartum condition, a systematic review of the seven randomized controlled trials (RCTs) provided no evidence to support FPO for intrapartum fetal monitoring. In the present review, we re-evaluate an overview for the use of FPO and seven RCTs of FPO. Methods: We reviewed numerous previous reports on FPO and seven RCTs of intrapartum FPO. RCTs were conducted with the main outcome measure being a reduction in the cesarean section rate. Results: The largest trial with 5341 entries failed to show any reduction. The negative result from this RCT may be explained by the use of a different cutoff value for fetal oxygen saturation compared to the other RCT; in addition, there were differences in the indications for cesarean section due to dystocia and in the definition of non-reassuring fetal status (NRFS). An abnormal FPO value, defined as the fetal oxygen saturation value <30% for at least 10 min, is useful for making a diagnosis of fetal acidosis. A newly developed device, an examiner's finger-mounted tissue oximetry, accurately measures tissue oxygen saturation while overcoming the drawbacks of FPO, such as infection risk and slipping off of the sensor during descent of the fetal head. Conclusion: FPO (including the new device) with fetal heart rate monitoring in selected cases of NRFS may reduce the cesarean section rate.
Introduction
Noninvasive methods of assessment of fetal wellbeing during pregnancy are preferable.
Currently, fetal heart rate (FHR) monitoring is the most commonly used method for the assessment of fetal wellbeing; however, it has a high false-positive rate. 1 This means that a fetus presenting with an abnormal FHR pattern is likely to have no abnormal conditions. Information about the FHR indirectly represents fetal hemodynamics and oxygenation status. In addition to FHR monitoring, the following procedures have been used to assess intrapartum fetal wellbeing: cordocentesis to collect fetal blood by needle puncture of the umbilical cord through the maternal abdominal wall, pH measurement by fetal scalp blood sampling, and implantation of pH electrodes into the fetus. However, all these procedures are invasive and have rarely been performed in current clinical settings. Pulse oximetry with near-infrared spectroscopy (NIRS) has been widely used in medical practice as a noninvasive measurement of oxygen saturation.
In the 1990s, obstetricians worldwide reported management of labor using fetal pulse oximetry (FPO). FPO measures fetal oxygenation status with a near-infrared sensor, which is inserted transvaginally and attached to the fetal head or cheek. Before 2006, management using FPO plus FHR monitoring reportedly reduced the rate of cesarean deliveries for the indication of nonreassuring fetal status (NRFS). FPO was thus regarded as useful in reducing the false-positive rates from FHR monitoring. However, Bloom et al. conducted a large randomized controlled trial (RCT) of FPO in 2006 and concluded that intrapartum measurement of FPO was not associated with a reduction in the rate of cesarean delivery or with improvement in the condition of the newborn. 2 Since this trial was a large RCT, it swayed the results of the systematic review of FPO by East et al. in 2014, which concluded that a combination of FPO and FHR monitoring did not reduce the overall cesarean section rate. 3 Limitations of the study by Bloom et al. were that they did not describe the number of cesarean deliveries indicated by the FPO results, nor did they describe countermeasures, including posture change according to the fetal oxygen saturation (FSpO 2 ) values, administration of tocolytic agents, and forced delivery. The number of papers on FPO has decreased after 2006 compared to before. We contest the conclusion that there is no evidence of usefulness of FPO, as this conclusion is heavily weighted by the results of the one large RCT. In 2015, we developed a new approach to measuring FSpO 2 with a sensor mounted on the examiner's finger, rather than attaching it to the fetus. Herein we review previous studies of FPO including the seven RCT, as well as present an overview of papers on the newly developed examiner's finger-mounted fetal tissue oximetry.
Development of FPO-Positive and Negative Results
In 1988, Peat et al. reported the successful measurement of intrapartum FSpO 2 using pulse oximetry with NIRS. 4 Subsequently, two papers in 1991 reported on continuous FPO monitoring each in approximately 100 deliveries. One paper reported that FSpO 2 decreased with dilatation of the uterine cervix. 5 The other reported that FSpO 2 was decreased in cases of fetal acidosis, fetal growth restriction, and breech presentation compared to that in cephalic presentation with normal growth. 6 However, at the early phase of the development of FPO, measurement during the second stage of labor was thought to produce significant measurement error due to movement interference. 7 Throughout the 1990s, many further studies on FPO were reported, most suggesting the usefulness of FPO in intrapartum fetal monitoring. [8] [9] [10] [11] [12] [13] [14] [15] [16] Of newborns who showed an abnormal intrapartum FHR pattern and had an operative delivery, some were born in good condition and others in poor condition (low Apgar scores); the FSpO 2 values in the newborns born in poor condition were low. 8 This suggested that FPO was able to identify the falsepositive results of FHR monitoring. FSpO 2 is reported to correlate with umbilical artery blood pH and hence to be an indicator of fetal acidosis. One multicenter study in 1999 investigated whether the durations of low, medium, and high FSpO 2 (≤30%, 31-60% and ≥60%, respectively) correlated with changes in umbilical artery blood pH. 14 This study revealed that the duration of low FSpO 2 was significantly longer in newborns with umbilical artery blood pH <7.15 than in those with pH ≥7. 15 . A prospective observational study in 2010 reported that duration of FSpO 2 <30% during the last 60 min before delivery showed a strong negative correlation with umbilical artery blood pH in cases of nonreassuring FHR (r 2 = 0.7, n = 101). 16 The fetuses with FSpO 2 <30% for at least 10 min were significantly more likely to show an umbilical artery blood pH <7.15 than those with low FSpO 2 for less than 10 min, when FSpO 2 values were measured with both the N-400 fetal pulse oximeter (Nellcor Inc.) and the FetalSAT pulse oximeter (Nonin Medical Inc.). The above results suggest that intrapartum FPO measurement predicts fetal acidosis. Fetal scalp blood sampling (FSBS), a method of measuring fetal blood pH directly, is challenging because it frequently causes complications, [17] [18] [19] [20] including massive bleeding, infection, and fetal cerebrospinal fluid leakage. If FPO measurement can be used instead of FSBS, it provides a noninvasive assessment of fetal oxygenation status.
On the other hand, several studies have not supported the usefulness of intrapartum FSpO 2 measurement. [21] [22] [23] [24] A study in 1994 of 20 fetuses reported that high quality FSpO 2 data were obtained for only 38.6% of the monitoring time after the membranes were ruptured, and concluded that FPO would not contribute to fetal assessment. 21 Another study using the N-400 fetal pulse oximeter examined the correlation between FSpO 2 and FSBS pH and reported no correlation between them. 22 In 2002, Rijnders et al. measured FSpO 2 for the last 30 minutes prior to delivery and reported no correlation between FSpO 2 and FSBS pH or umbilical artery blood pH immediately after delivery. 23 In 2001, the American College of Obstetricians and Gynecologists Committee stated that it did not endorse the use of FPO as a method for intrapartum fetal monitoring, and that RCT should be conducted to evaluate its efficacy. 24 
RCT of FPO
As of 2014, seven RCT of FPO have been reported and they were included in the systematic review by East et al. (Table 1) . 2, 3, [25] [26] [27] [28] [29] [30] Of these, five RCT compared FHR monitoring alone with FHR monitoring together with FPO; one RCT compared FHR monitoring, FPO and FSBS with FHR monitoring and FSBS; the remaining RCT compared FHR monitoring and FPO with FHR monitoring and fetal electrocardiography. In all the RCT, the main outcome measure was reduction in cesarean section rate, and Nellcor FPO was used in all the studies. In four RCT, [25] [26] [27] 29 the usefulness of FPO as intrapartum fetal monitoring, that is, reduction in the cesarean section rate, was demonstrated. In one of the three RCT that did not show a reduction in cesarean section rate, the decision-to-incision time of cesarean section for NRFS was shorter in the group using FPO. 27 The authors stated that there might be bias as the trial was not blinded and thus obstetricians used FSpO 2 values to guide indications for cesarean section. The high number of participants in the trial by Bloom et al. 2 would have influenced the conclusion of the systematic review. 3 In the trial by Bloom et al., dystocia was the indication for cesarean delivery in approximately 20% of the participants. However, in women with NRFS before randomization, the rate of cesarean delivery for NRFS was lower in the FHR monitoring with FPO group than in the FHR monitoring alone group, though this difference was not statistically significant (11.1% vs 9.9%, Table 2 ). There was a difference in FSpO 2 reference value for the delivery intervention between the three RCT with no significant difference in cesarean section rate and the four RCT with a significant difference. The study by Valverde et al. was quite different from the other six RCT in the following matters: FSpO 2 <10% was used as a reference value for delivery intervention (FSpO 2 <30% in the other six RCT), and the values measured during the second stage of labor were also used. 30 Detection the Cutoff Value of Fetal Oxygen Saturation during Labor Table 1 shows the cutoff FSpO 2 values in the seven RCT of FPO. Not only the FSpO 2 cutoff values but also the durations of abnormal values differed among the RCT. The duration of abnormal values in the four RCT that showed a reduction in cesarean section rate was at least 10 min, or the entire interval between two contractions, for FSpO 2 . The duration of abnormal values in the two RCT that showed no reduction in cesarean section rate was at least 2-3 min; hence, NRFS was diagnosed in a very short time. The assessment of the severity of NRFS changes depend on the duration of bradycardia in FHR monitoring. 31 Particularly in the cases of cesarean section for NRFS, the diagnostic criteria for NRFS greatly alter the results and conclusions of clinical research.
One study published in 1996 reported the relationship between umbilical artery blood oxygen saturation (SaO 2 ) and pH immediately after delivery. 31 Umbilical artery SaO 2 and pH values were measured in 1101 deliveries and receiver operating characteristic curves were generated to obtain the best SaO 2 cutoff value to determine NRFS. When the SaO 2 was ≥30% (n = 392), umbilical artery blood pH was ≥7.13 in 99% of cases and <7.13 in 1.0% of cases. When the SaO 2 was <30% (n = 709), umbilical artery blood pH was ≥7.13 in 91.4% of cases and <7.13 in 8.6% of cases. This study demonstrated that an FSpO 2 cutoff value of 30% would be optimal. A multicenter study of FPO in 1999 reported the prediction of fetal acidosis using SpO 2 values obtained with FPO during delivery.
14 In the study design, FSpO 2 values were classified into 'low' (≤30%), 'medium' (31-60%) and 'high' (>60%) categories. The authors analyzed the association of the durations (minutes) of the three categories during delivery with umbilical artery blood pH and neonatal Apgar score immediately after delivery. The authors performed FSBS several times to check the change in pH values. A total of 400 cases were analyzed. Newborns with a 1-min Apgar score <7 had a longer duration of 'low' FSpO 2 than those with a 1-min Apgar score ≥7. Newborns with pH <7.15 had a significantly longer duration of 'low' FSpO 2 than those with pH ≥7.15. The pH declined with a longer duration of 'low' FSpO 2 ; however, the decline was not observed unless FSpO 2 remained low for at least 10 min. This study defined the FSpO 2 cutoff value to be at least 30% for 10 min. In 2010, Nonnenmacher et al. investigated whether an FSpO 2 <30% for at least 10 min during the last 60 min before delivery was associated with fetal acidosis (umbilical artery blood pH <7.15) in the cases of NRFS on FHR monitoring during singleton cephalic delivery at ≥36 weeks of gestation. 16 An FSpO 2 value <30% for at least 10 min significantly 
25 Kuhnert et al. 26 Klauser et al. 27 East et al. 28 Bloom et al. 
Caput succedaneum
Caput succedaneum is formed on the fetal head during a prolonged labor. An analysis in 30 neonates showed that the SpO 2 value of the caput succedaneum was lower by an average of 15% than that of other areas. 33 The area of the fetal head to which the fetal oxygenation probe is attached should be changed in cases of significant caput succedaneum. On the other hand, a study by East et al. in 1996 reported no significant difference in the FspO 2 values between two probe attachment sites of the face of the same fetus. 34 
Uterine contraction
The association of uterine contraction with FSpO 2 has been examined. 35 A Nellcor FS14 fetal oxygen saturation sensor (Nellcor Puritan Bennett Inc.) and an intrauterine pressure catheter inserted transvaginally recorded changes in FSpO 2 values with and without a contraction. The mean FSpO 2 was high during a contraction and low 50 s following completion of a contraction. The mean signal quality was highest during a noncontraction period. However, the authors concluded that FSpO 2 was not affected by uterine contractions because the difference in FSpO 2 value with and without a contraction was small. A further study showed no significant change in FSpO 2 value with and without pushing for 30 minutes in the second stage of labor of normal neonates. 36 
Anesthesia during labor
A study assessing changes in FSpO 2 value before and after paracervical or epidural analgesia in pregnant women requiring pain relief in labor, showed a slightly increased FSpO 2 value 1 h after initiation of either of these forms of analgesia. 37 Another study reported the FSpO 2 results recorded at 5-min intervals for 30 min after initiation of anesthesia. 38 The mean FSpO 2 values were 49.5% 5 min before anesthesia, and 48.3%, 43% and 43.8% at 6-10 min, 21-25 min, and 26-30 min after anesthesia, respectively. The maternal position and FHR pattern did not influence FSpO 2 values. These two studies were both small, and the mechanism by which FSpO 2 values were affected was not explained. 
Oxygen supplement
Maternal oxygen supplementation is a clinical measure to protect against NRFS. It is interesting for obstetricians to determine whether maternal oxygen supplementation improves fetal oxygenation. Dildy et al. reported a significant increase in FSpO 2 from baseline in a group of women given 100% oxygen for 20 min with a normal FHR, but not in the groups receiving 40% oxygen. 41 Haydon et al., in a study where either 40% or 100% oxygen was administered to mothers with abnormal FHR monitoring, reported a significant increase in FSpO 2 in both the women who received 40% oxygen (mean increase, 4.9%) and those who received 100% oxygen (mean increase, 6.5%) compared to baseline values. 42 It remains unclear whether oxygen supplementation is actually beneficial for fetuses because it produces reactive oxygen species; however, oxygen supplementation is likely to increase FSpO 2 .
Development of a New Fetal Oximetry: Small Device Using Examiner's Mounting Probe
In a study published by Bloom et al. in 2006, the reported drawbacks of FPO included risks of infections, poor operability, a strong discomfort in pregnant women, and failure to measure FSpO 2 because of the detachment of the sensor with descent of the fetus during progress of delivery (i.e. a low rate of data acquisition). To overcome the drawbacks related to the placement of the sensor on the fetus, we developed an ultra-small NIRS sensor, which can be mounted on an examiner's finger to measure fetal tissue oxygen saturation during cervical examination (Fig. 1) . 43 This sensor allows noninvasive measurement of oxygenation of the body tissue nearly 5 mm deep from the body surface. The device measures arterial, venous and capillary blood oxygen saturation, unlike the conventional pulse oximeters that can only measure arterial blood oxygen saturation. It measures tissue oxygen saturation of the area to which its sensor is attached. Tissue oxygen saturation is also expressed as regional saturation of oxygen (rSO 2 ). This tissue oximetry measures total hemoglobin index (sum of oxyhemoglobin and deoxyhemoglobin). We launched a commercial product connecting this probe to a small portable monitor that can display the tissue oxygen saturation and total hemoglobin index (Fig. 2, KN-15, ASTEM) . The risk of intrauterine infection is reduced by covering the finger-mounted probe with a sterile glove, and the short duration of probe insertion.
We reported a pilot study of the device in 30 women during the second stage of labor. 44 The fetal rSO 2 (FrSO 2 ) correlated with umbilical artery blood pH (r = 0.52, P = 0.03). In the study to identify a FPO cutoff value, an FSpO 2 <30% for at least 10 min correlated with a reduction in umbilical artery blood pH. Similarly, in our pilot study of this new tissue oximetry, a correlation between FrSO 2 values and umbilical artery blood pH was demonstrated.
Since umbilical artery blood pH level is measured immediately after delivery, there is a time lag between the pH and intrapartum FrSO 2 measurements. In an animal model, we examined a correlation between rSO 2 and blood pH; the blood was collected from the rSO 2 measurement site (the cheeks of mice) immediately after delivery. 45 These two parameters showed a strong correlation (r = 0.90, P = 0.0009). This suggests that FrSO 2 values reflect real-time fetal blood pH levels, and hence FrSO 2 measurement may be used as a substitute for FSBS. It is difficult to place a pulse oximeter and measure SpO 2 in neonates immediately after birth, as it takes a few minutes for SpO 2 values to become stable. On the other hand, the newly developed tissue oximetry can immediately display measurement results. We reported that the device allowed rSO 2 measurement during appearing, crowning, and immediately before the first cry in fetal cranial tissue except the caput succedaneum. 46 In normal neonates, rSO 2 values slowly increase after birth, while in neonates who are admitted to a hospital because of respiratory disorders, the increase in rSO 2 value is delayed. Thus, rSO 2 measurement may be useful for newborn assessment soon after birth.
Conclusion
Fetal pulse oximetry may allow a direct examination for fetal acidosis; however, there is contradictory evidence from different trials. Nevertheless, FPO with FHR monitoring in selected cases of NRFS may reduce the cesarean section rate, and appears promising. Apart from caput succedaneum, few factors affect the measurement results. FSpO 2 values in cases of MAS can be an indicator of fetal wellbeing. A newly developed examiner's finger-mounted fetal tissue oximetry overcomes the drawbacks of FPO. A large clinical research trial is warranted to evaluate this device as a next-generation assessment tool for intrapartum fetal wellbeing.
